Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)

Clinical trial NCT01127074 · COMPLETED

Trial details

NCT number: NCT01127074
Sponsor: University Hospital Tuebingen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2002-03-01
Primary completion: 2008-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.